BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17635874)

  • 21. The Extracellular Domain of the β
    Ristow LC; Tran V; Schwartz KJ; Pankratz L; Mehle A; Sauer JD; Welch RA
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans.
    Balashova NV; Crosby JA; Al Ghofaily L; Kachlany SC
    Infect Immun; 2006 Apr; 74(4):2015-21. PubMed ID: 16552030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monodisperse and LPS-free Aggregatibacter actinomycetemcomitans leukotoxin: interactions with human β2 integrins and erythrocytes.
    Reinholdt J; Poulsen K; Brinkmann CR; Hoffmann SV; Stapulionis R; Enghild JJ; Jensen UB; Boesen T; Vorup-Jensen T
    Biochim Biophys Acta; 2013 Feb; 1834(2):546-58. PubMed ID: 23234758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cranberry Proanthocyanidins Neutralize the Effects of
    Ben Lagha A; Howell A; Grenier D
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31739483
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the Virulence of Aggregatibacter actinomycetemcomitans Through the Analysis of Leukotoxin.
    Nagasawa T; Kato S; Furuichi Y
    Methods Mol Biol; 2021; 2210():185-193. PubMed ID: 32815139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a quinol peroxidase mutant in Aggregatibacter actinomycetemcomitans.
    Takashima E; Konishi K
    FEMS Microbiol Lett; 2008 Sep; 286(1):66-70. PubMed ID: 18616592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggregatibacter actinomycetemcomitans Leukotoxin (LtxA) Requires Death Receptor Fas, in Addition to LFA-1, To Trigger Cell Death in T Lymphocytes.
    Vega BA; Schober LT; Kim T; Belinka BA; Kachlany SC
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31109948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sialic acid residues are essential for cell lysis mediated by leukotoxin from Aggregatibacter actinomycetemcomitans.
    Munksgaard PS; Skals M; Reinholdt J; Poulsen K; Jensen MR; Yang C; Leipziger J; Vorup-Jensen T; Praetorius HA
    Infect Immun; 2014 Jun; 82(6):2219-28. PubMed ID: 24643533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigallocatechin gallate inhibits leukotoxin release by Aggregatibacter actinomycetemcomitans by promoting association with the bacterial membrane.
    Chang EH; Giaquinto P; Huang J; Balashova NV; Brown AC
    Mol Oral Microbiol; 2020 Jan; 35(1):29-39. PubMed ID: 31816197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gangliosides block Aggregatibacter Actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis.
    Forman MS; Nishikubo JB; Han RK; Le A; Balashova NV; Kachlany SC
    Toxins (Basel); 2010 Dec; 2(12):2824-36. PubMed ID: 22069577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quinol peroxidase inhibitor prevents secretion of a leukotoxin from Aggregatibacter actinomycetemcomitans.
    Takashima E; Yamada H; Yajima A; Shiomi K; Omura S; Kiyoshi K
    J Periodontal Res; 2010 Feb; 45(1):123-8. PubMed ID: 19602106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggregatibacter actinomycetemcomitans leukotoxin causes activation of lymphocyte function-associated antigen 1.
    Nygren P; Balashova N; Brown AC; Kieba I; Dhingra A; Boesze-Battaglia K; Lally ET
    Cell Microbiol; 2019 Mar; 21(3):e12967. PubMed ID: 30329215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Actinobacillus actinomycetemcomitans leukotoxin forms large conductance, voltage-gated ion channels when incorporated into planar lipid bilayers.
    Lear JD; Furblur UG; Lally ET; Tanaka JC
    Biochim Biophys Acta; 1995 Aug; 1238(1):34-41. PubMed ID: 7544624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased leukotoxin production: Characterization of 100 base pairs within the 530 base pair leukotoxin promoter region of Aggregatibacter actinomycetemcomitans.
    Sampathkumar V; Velusamy SK; Godboley D; Fine DH
    Sci Rep; 2017 May; 7(1):1887. PubMed ID: 28507341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computational modeling and druggability assessment of Aggregatibacter actinomycetemcomitans leukotoxin.
    Hakmi M; Bouricha EM; El Harti J; Amzazi S; Belyamani L; Khanfri JE; Ibrahimi A
    Comput Methods Programs Biomed; 2022 Jul; 222():106952. PubMed ID: 35724475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxin-triggered liposomes for the controlled release of antibiotics to treat infections associated with the gram-negative bacterium, Aggregatibacter actinomycetemcomitans.
    Li Z; Baidoun R; Brown AC
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113870. PubMed ID: 38555763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggregatibacter actinomycetemcomitans leukotoxin is post-translationally modified by addition of either saturated or hydroxylated fatty acyl chains.
    Fong KP; Tang HY; Brown AC; Kieba IR; Speicher DW; Boesze-Battaglia K; Lally ET
    Mol Oral Microbiol; 2011 Aug; 26(4):262-76. PubMed ID: 21729247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggregatibacter (Actinobacillus) actimycetemcomitans leukotoxin and human periodontitis - A historic review with emphasis on JP2.
    Tsai CC; Ho YP; Chou YS; Ho KY; Wu YM; Lin YC
    Kaohsiung J Med Sci; 2018 Apr; 34(4):186-193. PubMed ID: 29655406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggregatibacter actinomycetemcomitans leukotoxin (LtxA; Leukothera) induces cofilin dephosphorylation and actin depolymerization during killing of malignant monocytes.
    Kaur M; Kachlany SC
    Microbiology (Reading); 2014 Nov; 160(Pt 11):2443-2452. PubMed ID: 25169107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of LtxA toxicity by blocking cholesterol binding with peptides.
    Brown AC; Koufos E; Balashova NV; Boesze-Battaglia K; Lally ET
    Mol Oral Microbiol; 2016 Feb; 31(1):94-105. PubMed ID: 26352738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.